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Healing Cells in the Dermis and Adipose Tissues of the Adult Pig
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ABSTRACT
Stage-specific antigen-4 (SSEA-4) positive cells and carcinoembryonic antigen-cell adhesion molecule-1 (CEA-
CAM-1) positive cells, indicative of pluripotent stem cells and totipotent stem cells, respectively, have been 
isolated and characterized from the skeletal muscle and blood of adult animals, including humans. The current 
study was undertaken to determine their location in the dermis and underlying connective tissues of the adult pig. 
Adult pigs were euthanized following the guidelines of Fort Valley State University’s IACUC. The skin (epidermis 
through hypodermis) was harvested, fixed, cryosectioned, and stained with the two antibodies: SSEA-4 and CEA-
CAM-1. SSEA-4 positive cells were located preferentially in the reticular dermis of the skin and to some extent 
in the underlying hypodermis. In contrast, CEA-CAM-1 positive stem cells were preferentially located within the 
hypodermis of the pig skin within the loose fibrous connective tissues surrounding adipose tissue. CEA-CAM-1 
positive cells were also located, to a lesser extent, in the dermis as well. These results demonstrate the presence of 
native populations of pluripotent stem cells and totipotent stem cells within the dermis, hypodermis, and adipose 
tissue of adult pig skin. Studies are ongoing to address the functional significance of these cells in normal injury 
and repair.
Keywords
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Introduction
There are three basic categories of cells within animals, i.e., 
functional cells, maintenance cells, and healing cells. The 
functional cells comprise the majority of the cell types and are 
composed of both stroma and parenchyma. They interact on a day-
to-day basis with the animal’s external and internal environments 
[1]. A few examples are of functional cells are adipocytes, 
fibrocytes, and myocytes. Maintenance cells support the functional 
cells on a daily basis by replacing functional cells as they wear 
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out and die as well as providing trophic factors for their function 
and survival. A few examples of maintenance cells are adipoblasts, 
fibroblasts, myoblasts, mesenchymal stem cells, medicinal 
secreting cells, and progenitor cells [1-6]. Healing cells are 
normally dormant and can be found hibernating within the stromal 
connective tissues throughout the body [7,8]. Their function is to 
replace functional cells and maintenance cells lost due to trauma 
and/or disease. Examples of healing cells are totipotent stem 
cells [1,6,8,9], pluripotent stem cells [1,6,10-12], ectodermal 
stem cells [1,6], mesodermal stem cells [1,6,13], and endodermal 
stem cells [1,6]. Healing cells comprise approximately 10% of 
all the cells of the body. They are ubiquitous, as they are found 
throughout all organs and tissues of the body. More specifically, 
totipotent stem cells comprise approximately 0.1%, pluripotent 
stem cells approximately 0.9%, and the ectodermal stem cells, 
mesodermal stem cells, and endodermal stem cells taken together, 
approximately 9% of all cells of the body [1,6,14].
The location, characterization, and activities of endogenous healing 
cells have been studied in skeletal muscle [2,8], bone marrow [15-
20], blood [10,21], adipose tissue [22], and at least 33 other tissues 
and organs within the body in multiple species of animals. Animals 
examined thus far include amphibians (Ambystoma Salamanders), 
reptiles (Komodo Dragon), avians (chicken, Waddel Crane), and 
12 species of mammals, including humans (i.e., mice, rats, rabbits, 
dogs, cats, sheep, goats, pigs, cows, Speckled Bear, horses, and 
humans) [1,6,7,10,23-29]. Healing cells have also been found in 
human umbilical cord, amnion, and placenta [30-32].
Native healing stem cells are located in the bone marrow (20), 
skeletal muscle (8), and blood stream (10,21) of various animal 
species. The current study was therefore designed to determine the 
location of healing cells in the skin of the adult pig. Discovery of 
these healing cells could provide an important initial step toward 
the ultimate goal of successful and safe cellular therapy for the 
treatment of a wide variety of conditions involving damage to the 
skin. 
Materials and Methods
Animal Use
The use of animals in this study complied with the guidelines of 
the Institutional Animal Care and Use Committee of Fort Valley 
State University and with the criteria of the National Research 
Council for the humane care of laboratory animals as outlined in 
the “Guide for the Care and Use of Laboratory Animals” prepared 
by the Institute of Laboratory Animal Resources and published by 
the National Institutes of Health (National Academy Press, 1996).
Tissue Harvest 
Twenty adult 120 lb. female Yorkshire pigs (n=20) were 
anesthetized with tiletamine and zolazepam, and then prepared 
for surgery with a Betadine wash. Sterile drapes were placed, and 
one-inch wide skin slices were made on either side of a midline 
laparotomy incision. The slices included the epidermis, dermis, 
and hypodermis with embedded adipose tissue. The skin was 
sliced into one-inch square pieces and placed in 500-ml wide-
mouth tissue culture jars (Corning, NY) containing 400-ml of 
cold ELICA fixative. The ELICA fixative consisted of aqueous 
0.4% v/v glutaraldehyde, 2% w/v paraformaldehyde, and 1% w/v 
glucose, Ph 7.4, with an osmolality 1.0 [8]. The porcine skin was 
allowed to remain in the fixative for 1 to 24 weeks at ambient 
temperature. After fixation, the skin was transferred and stored 
in Dulbecco’s Phosphate Buffered Saline (DPBS, Invitrogen, 
GIBCO, Grand Island, NY) at pH 7.4 and ambient temperature. 
Pieces of skin and associated adipose tissue were removed, placed 
into Tissue Tek OCT Compound 4583 (Miles Laboratory, Ames 
Division, Elkhart, IN) and then frozen at -20oC. The frozen pieces 
of skin were cryostat sectioned at seven microns in thickness with 
a Tissue Tek Cryostat II (GMI, Ramsey, MN), placed on positively 
charged slides (Mercedes Medical, Sarasota, FL) and refrigerated 
at -20oC. Immunocytochemical staining was performed following 
established procedures for ELICA analysis [8,33].
Immunocytochemistry
Seven-micron tissue sections were incubated with 95% ethanol to 
remove the OTC cryostat embedding medium and then washed 
under running water for five minutes. The tissue sections were 
incubated with 5.0% (w/v) sodium azide (Sigma, St. Louis, MO) in 
DPBS for 60 minutes. They were then washed in running water for 
five minutes, and incubated with 30% hydrogen peroxide (Sigma, 
St. Louis, MO) for 60 minutes to irreversibly inhibit endogenous 
peroxidases [34]. Tissue sections were rinsed with running water 
for five minutes and incubated for 60 minutes with blocking agent 
(Vecstatin ABC Reagent Kit, Vector Laboratories Inc., Burlingame, 
CA) in DPBS [33]. The blocking agent was removed and the 
sections rinsed with running water for five minutes. They were 
then incubated with primary antibody for 60 minutes. The primary 
antibodies consisted of 0.005% (v/v) carcinoembryonic antigen 
cell adhesion molecule-1 (CEA-CAM-1) in DPBS for totipotent 
stem cells [9]; 1 μg per ml of stage-specific embryonic antigen-4 
for pluripotent stem cells (SSEA-4, Developmental Studies 
Hybridoma Bank, Iowa City, IA) in DPBS [6,12]; and smooth 
muscle alpha-actin (IA4, Developmental Studies Hybridoma Bank) 
in DPBS [8,20]. The primary antibody was removed. The sections 
were rinsed with running water for five minutes, and incubated 
with secondary antibody for 60 minutes. The secondary antibody 
consisted of 0.005% (v/v) biotinylated affinity-purified, rat 
adsorbed anti-mouse immunoglobulin G (H + L) (BA-2001, Vector 
Laboratories) in DPBS [8]. The secondary antibody was removed. 
The sections were rinsed with running water for five minutes, and 
then incubated with avidin-HRP for 60 minutes. The avidin-HRP 
consisted of 10 ml of 0.1% (v/v) Tween-20 (ChemPure, Curtain 
Matheson Scientific, Houston, TX) containing 2 drops reagent-A 
and 2 drops reagent-B (Peroxidase Standard PK-4000 Vectastain 
ABC Reagent Kit, Vector Laboratories) in DPBS [8]. The avidin-
HRP was removed. The sections were rinsed with running water 
for five minutes, and incubated with AEC substrate (Sigma) for 
60 minutes. The AEC substrate was prepared as directed by the 
manufacturer. The substrate solution was removed. The sections 
were rinsed with running water for 10 minutes and then cover-
slipped with Aqua-mount (Vector Laboratories) [8].
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Positive and negative controls were included to assure the validity 
of the immunocytochemical staining [8]. The positive controls 
consisted of adult-derived totipotent stem cells (positive for CEA-
CAM-1) [8,9], pluripotent stem cells (positive for SSEA-4) [6,12], 
and smooth muscle surrounding blood vessels within the tissue 
(positive for IA4) [8,20]. The negative controls consisted of the 
staining protocol with DPBS alone (no antibodies or substrate), 
without primary antibodies (CEA-CAM-1, SSEA-4, or IA4), 
without secondary antibody (biotintylated anti-mouse IgG), 
without avidin-HRP, and without substrate (AEC) [8]. 
Visual Analysis 
Stained sections were visualized using a Nikon TMS phase contrast 
microscope with bright field microscopy at 40x, 100x, and 200x. 
Photographs were taken with a Nikon CoolPix 995 digital camera. 
Results
Cells that exhibited positive staining for CEA-CAM-1 were located 
in the loose fibrous connective tissue surrounding the adipose tissue 
in the hypodermis of adult porcine skin (Figure 1A), as well as in 
the fibrous connective tissue surrounding the blood vessels within 
the reticular layer of the dermis (Figure 1B). Cells that exhibited 
positive staining for SSEA-4 were located preferentially within 
the fibrous connective tissue of the reticular layer of the dermis 
of adult porcine skin (Figure 1C). Positive staining for smooth 
muscle alpha-actin was used as a positive procedural control. Such 
staining was apparent within the tunica media of a blood vessel 
located in the reticular layer of the dermis (Figure 1D). Negative 
procedural controls demonstrated absence of staining within the 
dermis or hypodermis of porcine skin (data not shown).
Figure 1: Cryosectioned porcine dermis and hypodermis.
A: CEA-CAM-1-positive cells located within loose fibrous connective 
tissue stroma surrounding unilocular white fat cells in hypodermis of 
porcine skin, 40x mag.
B: CEA-CAM-1-positive cells located within the fibrous connective 
tissue stroma surrounding an unstained arterial blood vessel within the 
reticular layer of the dermis, 200x mag.
C: SSEA-4-positive cells located within the fibrous connective tissue 
stroma in the border region between the reticular layer of the dermis and 
the hypodermis, 100x mag.
D: IA4-positive cells (positive procedural control for smooth muscle 
alpha-actin) within the tunica media of a vein within reticular layer of 
dermis. Note the presence of unstained red blood cells within the lumen 
of the vein. 200x mag.
Discussion
Young et al. previously reported the presence of totipotent stem 
cells (TSCs) and pluripotent stem cells (PSCs) in a variety of 
species of post-natal mammals [9,14,35]. Both stem cells have 
shown the capacity for extended self-renewal and the potential to 
form any somatic cell of the body. Stout et al. [28] demonstrated 
that these stem cells circulate in the peripheral blood as well as 
reside within the skeletal muscle of adult pigs. These cells were 
liberated from the skeletal muscle into the peripheral blood 
after only 90 minutes of trauma [28]. These findings led to the 
current study which identified and located CEA-CAM-1-positive 
totipotent stem cells and SSEA-4-positive pluripotent stem cells 
in adult porcine skin. Further studies are necessary to further 
characterize and utilize these cells in both veterinary and human 
therapeutic applications.
Clonal populations of totipotent stem cells and pluripotent stem 
cells have been derived by repetitive serial dilution clonogenic 
analysis in the adult rat [9,12]. These cells can differentiate 
to form cells belonging to all three germ layer lineages, i.e., 
ectoderm, mesoderm, and endoderm [6]. For example, rat brains 
were lesioned with 6-hydroxydopamine as a model of Parkinson 
disease. After stereotactic injection of Lac-Z-transfected 
undifferentiated pluripotent stem cells, the genomically-labeled 
stem cells formed dopaminergic neurons, cortical pyramidal 
neurons, interneurons, glial cells, and vasculature [36]. Another 
example involves lesioning of a coronary artery as a model of 
myocardial infarction. Cultured Lac-Z-transfected undifferentiated 
pluripotent stem cells were injected either directly into the 
area of the lesion or administered systemically by intravenous 
injection. These genomically-labeled cells incorporated into the 
myocardium, demonstrating a possible role in the restoration of 
the histoarchitecture of the damaged myocardium [12]. These 
same cells have also been shown to generate three-dimensional 
pancreatic islet-like structures that responded to a glucose 
challenge by secretion of species-specific insulin [37]. Taken 
together, these results suggest that the regeneration and repair of 
one organ or tissue may be accomplished by totipotent stem cells 
and pluripotent stem cells residing in another organ or tissue.
Much of the research on therapeutic approaches to the treatment of 
inherited skin disorders, such as xeroderma pigmentosum, involves 
the use of gene therapy employing a viral vector [38]. Young et 
al. proposed that pluripotent stem cells could provide a means for 
delivery of gene therapy without loss of the development potential 
of the stem cells themselves [14]. Thus, based on the Lac-Z 
genomically-labeling studies [12,36], a transfected pluripotent stem 
cell could serve as a vector for gene therapy while simultaneously 
providing a source of cells with normal tissue function.
Skin ages as a consequence of decreased cutaneous elasticity and 
resilience [39]. The development of wrinkled skin is associated 
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with increased susceptibility of elastic fibers in the dermal 
extracellular matrix to proteolytic degradation. These changes 
are a consequence of the inability of adult dermal fibroblasts to 
synthesize elastin to replace the degraded elastic fibers. Healing 
cells (in the form of totipotent stem cells, pluripotent stem 
cells, and/or mesodermal stem cells), could provide a source of 
functional pre-fibroblasts or cells that provide fibroblasts with the 
appropriate signals required for their survival. In addition to their 
possible uses for cosmetic purposes in the treatment of aging in 
skin, dermal stem cells could provide a possible treatment option 
for inherited diseases that impair the deposition of elastic fibers.
Ectodermal stem cells are known to exist in the bulge of the hair 
follicle. Such stem cells are capable of regenerating the hair follicle 
and epidermis in response to burns or other types of wounds [40]. 
Stem cells in the follicular bulge are damaged in certain types of 
alopecia, particularly those involving inflammation and permanent 
loss of follicles [41]. Healing cells, such as totipotent stem cells 
and pluripotent stem cells, isolated from various tissue locations 
such as the dermis [this study,7], adipose tissues [this study,22], 
skeletal muscle [7,8,25,28], blood [10,21,28,29], or bone marrow 
[11,17,19,20], may provide a source of functional stem cells 
for repopulating the follicular bulge to facilitate therapeutic 
regeneration of hair.
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